Patent Eligibility Requirements Under US Law
Patent eligibility under US law determines whether an invention qualifies for patent protection before examination of novelty, non-obviousness, or utility. This page covers the four statutory requirements under Title 35 of the US Code, the judicial exceptions that have reshaped eligibility doctrine since 2014, the classification boundaries between eligible and ineligible subject matter, and the procedural sequence the USPTO applies during examination.
- Definition and Scope
- Core Mechanics or Structure
- Causal Relationships or Drivers
- Classification Boundaries
- Tradeoffs and Tensions
- Common Misconceptions
- Checklist or Steps
- Reference Table or Matrix
Definition and Scope
Patent eligibility is the threshold question the United States Patent and Trademark Office (USPTO) applies before any other patentability inquiry: does the claimed invention fall within a statutory category of protectable subject matter under 35 U.S.C. § 101? If a claim fails § 101, the application is rejected regardless of how novel or non-obvious the invention may be.
The statute identifies four eligible categories: processes, machines, manufactures, and compositions of matter. These four categories are interpreted broadly, but three judicially created exceptions — laws of nature, natural phenomena, and abstract ideas — carve out subject matter that courts have held falls outside patent protection even when it nominally fits a statutory category. The Supreme Court has affirmed these exceptions in decisions including Mayo Collaborative Services v. Prometheus Laboratories (2012) and Alice Corp. v. CLS Bank International (2014), the latter of which fundamentally altered software patent eligibility analysis.
Patent eligibility intersects with the broader regulatory context for patent law, including Congressional mandates, USPTO rulemaking authority, and the evolving standards applied by the Patent Trial and Appeal Board (PTAB). A full orientation to patent law's scope and structure is available on the site index.
Core Mechanics or Structure
The Four Statutory Categories
Under 35 U.S.C. § 101, any new and useful process, machine, manufacture, or composition of matter — or any new and useful improvement thereof — may obtain a patent. These categories collectively encompass the vast majority of technological inventions:
- Process: A series of steps or acts, including software-implemented methods and industrial processes.
- Machine: A device with moving or interacting parts producing a result, including computer systems.
- Manufacture: An article produced from raw or prepared materials, including electronic components.
- Composition of matter: Chemical compounds, mixtures, and biological materials, including pharmaceutical formulations.
The Two-Step Alice/Mayo Framework
The USPTO applies the two-step framework established in Alice and Mayo — codified in the USPTO's 2019 Revised Patent Subject Matter Eligibility Guidance (84 Fed. Reg. 50) — to evaluate whether a claim falls within a judicial exception:
Step 1: Determine whether the claim is directed to one of the four statutory categories.
Step 2A, Prong 1: Evaluate whether the claim is directed to a judicial exception — specifically, a law of nature, a natural phenomenon, or an abstract idea (including mathematical concepts, certain methods of organizing human activity, and mental processes).
Step 2A, Prong 2: If a judicial exception is recited, determine whether the additional claim elements integrate the exception into a practical application — meaning the exception is applied in a way that imposes a meaningful limit beyond the exception itself.
Step 2B: If the claim does not integrate the exception into a practical application, determine whether the additional elements provide an inventive concept — something significantly more than the judicial exception alone.
This two-step analysis governs every § 101 rejection issued by USPTO examiners and every eligibility challenge before the PTAB. The section 101 patent eligibility doctrine receives dedicated treatment for software and business method claims.
Causal Relationships or Drivers
Judicial Narrowing of § 101
The current restrictive eligibility environment traces directly to three Supreme Court decisions issued between 2010 and 2014. In Bilski v. Kappos (2010), the Court rejected the Federal Circuit's machine-or-transformation test as the sole eligibility standard. In Mayo (2012), the Court held that a method of calibrating drug dosages based on natural metabolite levels was ineligible because it added nothing beyond the law of nature itself. In Alice (2014), the Court applied the Mayo framework to invalidate software-implemented financial risk management claims, triggering a wave of § 101 rejections across computer-implemented inventions.
Following Alice, the USPTO's grant rate for software-related patent applications dropped measurably. A 2016 Government Accountability Office report noted that USPTO allowance rates in Class 705 (data processing for financial, business, and management applications) declined significantly in the years immediately after Alice. The Federal Circuit has since decided over 200 § 101 cases, producing a body of case law that practitioners describe as fact-specific and difficult to predict with consistency.
Legislative and Administrative Responses
Congress has considered legislation to reform § 101 — including draft proposals circulated by the Senate Judiciary Committee's IP Subcommittee — but no statute amending § 101 had been enacted as of the publication of the USPTO's most recent examination guidance. The USPTO has issued supplemental guidance documents in 2019 and 2020 clarifying how examiners should apply Step 2A, Prong 2, with additional examples organized by technology area including life sciences, software, and business methods (USPTO Subject Matter Eligibility Resources).
Classification Boundaries
What Is Categorically Eligible
- Genetically modified organisms that differ markedly from naturally occurring organisms (Diamond v. Chakrabarty, 450 U.S. 303 (1980))
What Is Categorically Ineligible
- Products of nature in their natural form, including isolated genomic DNA in the sequence found in nature (Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 576 (2013))
The Gray Zone: Software and AI
Software patent law operates in a contested middle ground. Claims directed to a specific improvement in computer functionality — such as a new data compression algorithm that reduces memory consumption — can survive § 101 analysis under Enfish, LLC v. Microsoft Corp. (Fed. Cir. 2016). Claims that merely apply a generic computer to implement an otherwise abstract financial or organizational method remain ineligible. Artificial intelligence patents face identical analysis: AI methods tied to specific improvements in model architecture or processing efficiency fare better than claims covering general-purpose AI application.
Biotechnology patent law raises distinct eligibility challenges around naturally derived compounds, diagnostic methods, and gene editing technologies, while pharmaceutical patent law routinely navigates eligibility barriers around formulation methods and dosage regimens.
Tradeoffs and Tensions
Breadth vs. Eligibility
Broad claims covering a general inventive concept maximize commercial protection but are more vulnerable to § 101 rejection. Narrow claims tied to specific technical implementations are more likely to survive eligibility scrutiny but provide weaker exclusionary scope. Patent applicants must balance these opposing pressures during patent claims drafting.
Innovation Incentive vs. Public Domain Preservation
The judicial exceptions exist specifically to prevent patents from preempting fundamental principles that all inventors must use. A patent on a law of nature would, in effect, block all downstream innovation that depends on that law. The preemption concern — articulated in Mayo and Alice — reflects a structural tension between the incentive function of patent exclusivity and the need to maintain scientific building blocks in the public domain.
Domestic Competitiveness and International Divergence
US § 101 doctrine is stricter than patent eligibility standards in the European Patent Convention, where software claims face exclusion only if they lack a "technical character," a standard that many practitioners consider more permissive than the Alice two-step framework. This divergence means that an invention may obtain patent protection in Europe under international patent protection frameworks while facing rejection at the USPTO on § 101 grounds — creating asymmetric global patent portfolios.
Common Misconceptions
Misconception: Any computer-implemented invention is patent-eligible.
Correction: Computer implementation alone does not satisfy § 101. The claim must do more than apply an abstract idea using generic computer hardware. The Federal Circuit held in Alice that reciting a computer does not transform an otherwise ineligible abstract concept into patent-eligible subject matter.
Misconception: Natural compounds are never patentable.
Correction: Naturally occurring compounds isolated and purified in forms that do not exist in nature, and that possess specific utility, can be eligible. Myriad excluded naturally occurring genomic DNA sequences but left open the eligibility of cDNA and other structurally modified derivatives that differ from natural forms.
Misconception: § 101 eligibility is the same as patentability.
Correction: Eligibility under § 101 is only one of four independent patentability requirements. Even a § 101-eligible claim must separately satisfy novelty (35 U.S.C. § 102), non-obviousness (35 U.S.C. § 103), and written description/enablement (35 U.S.C. § 112).
Misconception: A § 101 rejection cannot be overcome.
Correction: § 101 rejections are overcome regularly by amending claims to more specifically tie the invention to a practical application or technological improvement, or by presenting arguments that the claim integrates the exception into a specific practical application under Step 2A, Prong 2 of the USPTO's guidance.
Checklist or Steps
The following sequence reflects the analytical framework applied during USPTO examination and in Federal Circuit litigation. It is presented as a structural reference, not professional guidance.
Step 1 — Identify the statutory category
Determine whether the claim as a whole is directed to a process, machine, manufacture, or composition of matter under 35 U.S.C. § 101.
Step 2 — Identify the claim's focus
Parse each claim element to identify whether any element recites a judicial exception: (a) a mathematical concept, (b) a mental process, (c) a method of organizing human activity, (d) a law of nature, or (e) a natural phenomenon.
Step 3 — Apply Step 2A, Prong 1
Determine whether the claim as a whole is directed to the identified judicial exception, or whether the exception is incidental to the claim's overall focus on a practical application.
Step 4 — Apply Step 2A, Prong 2
Assess whether additional claim elements beyond the judicial exception integrate the exception into a practical application — for example, by improving a technical process, being applied with a particular machine, or producing a particular transformation.
Step 5 — Apply Step 2B (if needed)
If the claim does not integrate the exception into a practical application, evaluate whether the additional elements provide an inventive concept that is significantly more than the judicial exception alone — something beyond well-understood, routine, and conventional activity.
Step 6 — Document the analysis
Record the basis for the eligibility determination with reference to specific claim elements and analogous Federal Circuit precedent.
Step 7 — Consider claim amendments
If eligibility is not established, identify whether claim narrowing, additional technical limitations, or structural amendments to emphasize the practical application could bring the claim within an eligible scope.
Reference Table or Matrix
| Claim Type | Statutory Category | Primary Eligibility Risk | Key Precedent | Typical Outcome Pathway |
|---|---|---|---|---|
| Software business method | Process | Abstract idea — organizing human activity | Alice Corp. v. CLS Bank (2014) | Fails Step 2A unless tied to specific technical improvement |
| Drug dosage calibration method | Process | Law of nature — natural correlation | Mayo v. Prometheus (2012) | Fails unless claim adds inventive concept beyond the natural law |
| Isolated natural DNA | Composition of matter | Product of nature — natural genomic sequence | Myriad Genetics (2013) | Ineligible; cDNA may be eligible |
| AI model training method | Process | Abstract idea — mathematical concept | Alice framework; Enfish (Fed. Cir. 2016) | Eligible if tied to specific improvement in computer functionality |
| Chemical compound (synthetic) | Composition of matter | Low risk if distinct from natural compounds | Chakrabarty (1980) | Generally eligible with utility showing |
| Diagnostic correlation method | Process | Law of nature — biological marker correlation | Mayo (2012); Ariosa v. Sequenom (Fed. Cir. 2015) | High rejection risk without unconventional application steps |
| Mechanical manufacturing process | Process | Minimal risk — concrete transformation | Bilski (2010) machine-or-transformation test | Generally eligible |
| Software improving computer function | Process | Abstract idea — mathematical algorithm | Enfish, LLC v. Microsoft (Fed. Cir. 2016) | Eligible if improvement is to the computer itself, not just using a computer |
References
- United States Patent and Trademark Office (USPTO)
- 35 U.S.C. § 101
- 2019 Revised Guidance on Patent Subject Matter Eligibility
- USPTO Subject Matter Eligibility Resources
- Cornell Law — Legal Information Institute
- Congress.gov — U.S. Legislative Information
- U.S. Department of Justice
- FTC — Legal Resources